Effects of medication adherence on disease activity in chronic obstructive pulmonary disease: a systematic review and meta-analysis

References

• Ágh, T., Inotai, A., & Mészáros, Á. (2011). Factors associated with medication adherence in patients with chronic obstructive pulmonary disease. Respiration; International Review of Thoracic Diseases, 82(4), 328–334. https://doi.org/10.1159/000324453
   PubMed Web of Science ®Google Scholar
• Alcazar, B., de Lucas, P., Soriano, J. B., Fernández-Nistal, A., Fuster, A., González-Moro, J. M., Arnedillo, A., Sidro, P. G., & de Los Monteros, M. J. (2016). The evaluation of a remote support program on quality of life and evolution of disease in COPD patients with frequent exacerbations. BMC Pulmonary Medicine, 16(1), 140. https://doi.org/10.1186/s12890-016-0304-3
   PubMedGoogle Scholar
• Attaway, A. H., Alshabani, K., Bender, B., & Hatipoğlu, U. S. (2020). The utility of electronic inhaler monitoring in COPD management: Promises and challenges. Chest, 157(6), 1466–1477. https://doi.org/10.1016/j.chest.2019.12.034
   PubMed Web of Science ®Google Scholar
• Bhattarai, B., Walpola, R., Mey, A., Anoopkumar-Dukie, S., & Khan, S. (2020). Barriers and strategies for improving medication adherence among people living with COPD: A systematic review. Respiratory Care, 65(11), 1738–1750. https://doi.org/10.4187/respcare.07355
   PubMed Web of Science ®Google Scholar
• Boland, M. R., van Boven, J. F., Kruis, A. L., Chavannes, N. H., van der Molen, T., Goossens, L. M., & Rutten-van Mölken, M. P. (2016). Investigating the association between medication adherence and health-related quality of life in COPD: Methodological challenges when using a proxy measure of adherence. Respiratory Medicine, 110, 34–45. https://doi.org/10.1016/j.rmed.2015.11.008
   PubMed Web of Science ®Google Scholar
• Celli, B., Locantore, N., Yates, J. C., Bakke, P., Calverley, P., Crim, C., Coxson, H. O., Lomas, D. A., MacNee, W., Miller, B. E., Mullerova, H., Rennard, S. I., Silverman, E. K., Wouters, E., Tal-Singer, R., Agusti, A., & Vestbo, J. Evaluation of COPD longitudinally to identify predictive surrogate endpoints (ECLIPSE) Investigators (2021) Markers of disease activity in COPD: An 8-year mortality study in the ECLIPSE cohort. The European Respiratory Journal, 57(3), 2001339. https://doi.org/10.1183/13993003.01339-2020
   Google Scholar
• Chen, R., Gao, Y., Wang, H., Shang, H., & Xuan, J. (2020). Association between adherence to maintenance medication in patients with COPD and acute exacerbation occurrence and cost in China: A retrospective cohort database study. International Journal of Chronic Obstructive Pulmonary Disease, 15, 963–971. https://doi.org/10.2147/COPD.S234349
   PubMed Web of Science ®Google Scholar
• Chen, S., Small, M., Lindner, L., & Xu, X. (2018). Symptomatic burden of COPD for patients receiving dual or triple therapy. International Journal of Chronic Obstructive Pulmonary Disease, 13, 1365–1376. https://doi.org/10.2147/COPD.S163717
   PubMed Web of Science ®Google Scholar
• Dekhuijzen, R., Lavorini, F., Usmani, O. S., & van Boven, J. (2018). Addressing the impact and unmet needs of nonadherence in asthma and chronic obstructive pulmonary disease: Where do we go from Here? The Journal of Allergy and Clinical Immunology in Practice, 6(3), 785–793. https://doi.org/10.1016/j.jaip.2017.11.027
   PubMed Web of Science ®Google Scholar
• Duarte-de-Araújo, A., Teixeira, P., Hespanhol, V., & Correia-de-Sousa, J. (2018). COPD: Understanding patients’ adherence to inhaled medications. International Journal of Chronic Obstructive Pulmonary Disease, 13, 2767–2773. https://doi.org/10.2147/COPD.S160982
   PubMed Web of Science ®Google Scholar
• Duarte-de-Araújo, A., Teixeira, P., Hespanhol, V., & Correia-de-Sousa, J. (2020). COPD: Analysing factors associated with a successful treatment. Pulmonology, 26(2), 66–72. https://doi.org/10.1016/j.pulmoe.2019.05.012
   PubMed Web of Science ®Google Scholar
• Fens, T., Zhou, G., Postma, M. J., van Puijenbroek, E. P., & van Boven, J. (2021). Economic evaluations of chronic obstructive pulmonary disease pharmacotherapy: How well are the real-world issues of medication adherence, comorbidities and adverse drug-reactions addressed? Expert Opinion on Pharmacotherapy, 22(7), 923–935. https://doi.org/10.1080/14656566.2021.1873953
   PubMed Web of Science ®Google Scholar
• GBD 2017 Causes of Death Collaborators. (2018). Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet (London, England), 392(10159), 1736–1788. https://doi.org/10.1016/S0140-6736(18)32203-7
   PubMed Web of Science ®Google Scholar
• Higgins, J. P., & Thompson, S. G. (2002). Quantifying heterogeneity in a meta-analysis. Statistics in Medicine, 21(11), 1539–1558. https://doi.org/10.1002/sim.1186
   PubMed Web of Science ®Google Scholar
• Humenberger, M., Horner, A., Labek, A., Kaiser, B., Frechinger, R., Brock, C., Lichtenberger, P., & Lamprecht, B. (2018). Adherence to inhaled therapy and its impact on chronic obstructive pulmonary disease (COPD). BMC Pulmonary Medicine, 18(1), 163. https://doi.org/10.1186/s12890-018-0724-3
   PubMedGoogle Scholar
• Jarab, A. S., & Mukattash, T. L. (2019). Exploring variables associated with medication non-adherence in patients with COPD. International Journal of Clinical Pharmacy, 41(5), 1202–1209. https://doi.org/10.1007/s11096-019-00895-3
   PubMed Web of Science ®Google Scholar
• Jia, X., Zhou, S., Luo, D., Zhao, X., Zhou, Y., & Cui, Y. M. (2020). Effect of pharmacist-led interventions on medication adherence and inhalation technique in adult patients with asthma or COPD: A systematic review and meta-analysis. Journal of Clinical Pharmacy and Therapeutics, 45(5), 904–917. https://doi.org/10.1111/jcpt.13126
   PubMed Web of Science ®Google Scholar
• López-Pintor, E., Grau, J., González, I., Bernal-Soriano, M. C., Lumbreras, B., & Lumbreras, B. (2020). Impact of patients’ perception of COPD and treatment on adherence and health-related quality of life in real-world: Study in 53 community pharmacies. Respiratory Medicine, 176, 106280. https://doi.org/10.1016/j.rmed.2020.106280
   PubMed Web of Science ®Google Scholar
• Miravitlles, M., Marín, A., Huerta, A., Carcedo, D., Villacampa, A., & Puig-Junoy, J. (2020). Estimation of the clinical and economic impact of an improvement in adherence based on the use of once-daily Single-Inhaler triple therapy in patients with COPD. International Journal of Chronic Obstructive Pulmonary Disease, 15, 1643–1654. https://doi.org/10.2147/COPD.S253567
   PubMed Web of Science ®Google Scholar
• Moher, D., Liberati, A., Tetzlaff, J., & Altman, D. G.; PRISMA Group. (2009). Reprint–preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. Physical Therapy, 89(9), 873–880.
   PubMed Web of Science ®Google Scholar
• Montes de Oca, M., Menezes, A., Wehrmeister, F. C., Lopez Varela, M. V., Casas, A., Ugalde, L., Ramirez-Venegas, A., Mendoza, L., López, A., Surmont, F., & Miravitlles, M. (2017). Adherence to inhaled therapies of COPD patients from seven Latin American countries: The LASSYC study. PloS One, 12(11), e0186777. https://doi.org/10.1371/journal.pone.0186777
   PubMed Web of Science ®Google Scholar
• Müllerová, H., Landis, S. H., Aisanov, Z., Davis, K. J., Ichinose, M., Mannino, D. M., Maskell, J., Menezes, A. M., van der Molen, T., Oh, Y. M., Tabberer, M., & Han, M. K. (2016). Health behaviors and their correlates among participants in the Continuing to Confront COPD International Patient Survey. International Journal of Chronic Obstructive Pulmonary Disease, 11, 881–890. https://doi.org/10.2147/COPD.S102280
   PubMed Web of Science ®Google Scholar
• Nguyen, T. S., Nguyen, T., Pham, T., Hua, S., Ngo, Q. C., & Li, S. C. (2019). Impact of pharmaceutical care in the improvement of medication adherence and quality of life for COPD patients in Vietnam. Respiratory Medicine, 153, 31–37. https://doi.org/10.1016/j.rmed.2019.05.006
   PubMed Web of Science ®Google Scholar
• Osterberg, L., & Blaschke, T. (2005). Adherence to medication. The New England Journal of Medicine, 353(5), 487–497. https://doi.org/10.1056/NEJMra050100
   PubMed Web of Science ®Google Scholar
• Plaza, V., López-Viña, A., Entrenas, L. M., Fernández-Rodríguez, C., Melero, C., Pérez-Llano, L., Gutiérrez-Pereyra, F., Tarragona, E., Palomino, R., & Cosio, B. G. (2016). Differences in adherence and non-adherence behaviour patterns to inhaler devices between COPD and asthma patients. COPD, 13(5), 547–554. https://doi.org/10.3109/15412555.2015.1118449
   PubMedGoogle Scholar
• Rabe, K. F., & Watz, H. (2017). Chronic obstructive pulmonary disease. Lancet (London, England), 389(10082), 1931–1940. https://doi.org/10.1016/S0140-6736(17)31222-9
   PubMed Web of Science ®Google Scholar
• Singh, D., Criner, G. J., Naya, I., Jones, P. W., Tombs, L., Lipson, D. A., & Han, M. K. (2020). Measuring disease activity in COPD: Is clinically important deterioration the answer? Respiratory Research, 21(1), 134. https://doi.org/10.1186/s12931-020-01387-z
   PubMed Web of Science ®Google Scholar
• Sriram, K. B., & Percival, M. (2016). Suboptimal inhaler medication adherence and incorrect technique are common among chronic obstructive pulmonary disease patients. Chronic Respiratory Disease, 13(1), 13–22. https://doi.org/10.1177/1479972315606313
   PubMed Web of Science ®Google Scholar
• Stang, A. (2010). Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. European Journal of Epidemiology, 25(9), 603–605. https://doi.org/10.1007/s10654-010-9491-z
   PubMed Web of Science ®Google Scholar
• Stroup, D. F., Berlin, J. A., Morton, S. C., Olkin, I., Williamson, G. D., Rennie, D., Moher, D., Becker, B. J., Sipe, T. A., & Thacker, S. B. (2000). Meta-analysis of observational studies in epidemiology: A proposal for reporting meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA, 283(15), 2008–2012. https://doi.org/10.1001/jama.283.15.2008
   PubMed Web of Science ®Google Scholar
• Świątoniowska, N., Chabowski, M., Polański, J., Mazur, G., & Jankowska-Polańska, B. (2020). Adherence to therapy in chronic obstructive pulmonary disease: A systematic review. Advances in Experimental Medicine and Biology, 1271, 37–47. https://doi.org/10.1007/5584_2019_477
   PubMed Web of Science ®Google Scholar
• Takemura, M., Mitsui, K., Itotani, R., Ishitoko, M., Suzuki, S., Matsumoto, M., Aihara, K., Oguma, T., Ueda, T., Kagioka, H., & Fukui, M. (2011). Relationships between repeated instruction on inhalation therapy, medication adherence, and health status in chronic obstructive pulmonary disease. International Journal of Chronic Obstructive Pulmonary Disease, 6, 97–104. https://doi.org/10.2147/COPD.S16173
   PubMed Web of Science ®Google Scholar
• Vogelmeier, C. F., Criner, G. J., Martinez, F. J., Anzueto, A., Barnes, P. J., Bourbeau, J., Celli, B. R., Chen, R., Decramer, M., Fabbri, L. M., Frith, P., Halpin, D. M., López Varela, M. V., Nishimura, M., Roche, N., Rodriguez-Roisin, R., Sin, D. D., Singh, D., Stockley, R., Agustí, A. (2017). Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report GOLD executive summary. American Journal of Respiratory and Critical Care Medicine, 195(5), 557–582. https://doi.org/10.1164/rccm.201701-0218PP
   PubMed Web of Science ®Google Scholar
• Vrijens, B., Dima, A. L., Van Ganse, E., van Boven, J. F., Eakin, M. N., Foster, J. M., de Bruin, M., Chisholm, A., & Price, D. (2016). What we mean when we talk about adherence in respiratory medicine. The Journal of Allergy and Clinical Immunology in Practice, 4(5), 802–812. https://doi.org/10.1016/j.jaip.2016.05.019
   PubMed Web of Science ®Google Scholar
• WHO.(2020).COPD:Definition.Retrieved Sept 28, 2021, from:https://www.who.int/respiratory/copd/definition/en/
   Google Scholar
• Willard-Grace, R., Chirinos, C., Wolf, J., DeVore, D., Huang, B., Hessler, D., Tsao, S., Su, G., & Thom, D. H. (2020). Lay health coaching to increase appropriate inhaler use in COPD: A randomized controlled trial. Annals of Family Medicine, 18(1), 5–14. https://doi.org/10.1370/afm.2461
   PubMed Web of Science ®Google Scholar
• World Health Organization.(2019).Projections of mortality and causes of death,2016 to 2060. Retrieved Feb 20,2021,from:https://www.who.int/healthinfo/global_burden_disease/projections/en/
   Google Scholar
• Zhou, M., Wang, H., Zeng, X., Yin, P., Zhu, J., Chen, W., Li, X., Wang, L., Wang, L., Liu, Y., Liu, J., Zhang, M., Qi, J., Yu, S., Afshin, A., Gakidou, E., Glenn, S., Krish, V. S., Miller-Petrie, M. K., Liang, X. (2019). Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: A systematic analysis for the global burden of disease study 2017. Lancet (London, England), 394(10204), 1145–1158. https://doi.org/10.1016/S0140-6736(19)30427-1
   PubMed Web of Science ®Google Scholar